Sarepta Therapeutics Balance Sheet - Quarterly (NASDAQ:SRPT)

Add to My Stocks
$35.81 $1.79 (5.26%) SRPT stock closing price Apr 25, 2017 (Closing)

The financial analysis of a company like Sarepta Therapeutics involves checking the three financial statements of the company in detail, of which the balance sheet is one. Financial strength can be guaged by performing Sarepta Therapeutics stock analysis and by analyzing the balance sheet. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Sarepta Therapeutics had a long term debt of $6.04M at the end of 2016-Q4. Sarepta Therapeutics operating cash flow was $-245.82M while Sarepta Therapeutics revenue stood at $5.42M. View Sarepta Therapeutics quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Marketable Securities206.12M10.69M101.85M122.88M44.09M87.34M91.78M136.79M187.71M180.78M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets26.89M22M16.88M17.38M19.46M23.09M24.41M35.03M26.43M15.9M
Sarepta Therapeutics Total Current Assets
Property Plant & Equipment68.14M64.04M62.8M61.93M60.74M59.38M58.79M58.39M56.04M38.1M
Accumulated Depreciation30.34M28.42M25.82M24.59M23.36M22.19M21.03M19.89M18.86M17.94M
Sarepta Therapeutics Net Property Plant & Equipment
Investment & Advances0.78M0.78M0.78M0.78M11.47M0.78M0.78M0.78M0.64M0.64M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets3.96M8.05M8.14M4.47M7.67M5.31M5.27M2.06M5.72M6.44M
Sarepta Therapeutics Total Assets
Notes Payable-2.49M--------
Accounts Payable29.69M20.68M18.67M20.23M7.43M14.09M9.31M12.4M0.96M1.3M
Current Portion Long-Term Debt10.1M10.1M7.6M5.93M3.43M0.1M0.09M0.09M0.09M0.09M
Current Portion Capital Leases----------
Accrued Expenses31.01M29.53M24.27M29.05M19.76M15.18M15.03M17.36M14.82M13.83M
Income Taxes Payable----------
Other Current Liabilities4.6M4.6M4.6M4.57M4.58M4.67M4.61M4.5M4.42M14.16M
Sarepta Therapeutics Total Current Liabilities
Deferred Taxes/Income5.94M5.26M5.86M6.17M6.45M6.72M6.59M6.77M6.36M6.45M
Convertible Debt----------
Long-Term Debt6.04M8.49M13.37M14.96M17.39M20.65M1.45M3.73M3.76M1.52M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Sarepta Therapeutics Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M0.01M0.01M------
Capital Surplus1.5B1.49B1.1B1.09B957.6M947.82M941.35M926.76M920.86M905.33M
Retained Earnings-1.17B-1.08B-958.82M-899.05M-834.37M-782.43M-740.58M-679.02M-634.6M-605.38M
Treasury Stock----------
Other Liabilities-0.12M--0.01M-0.11M--0.01M-0.01M-0.09M-0.05M-0.03M
Sarepta Therapeutics Shareholders Equity
Sarepta Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

The latest Sarepta Therapeutics stock price, and Sarepta Therapeutics historical stock prices show the stock price movement over time, and the Sarepta Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: Anything that the Sarepta Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Sarepta Therapeutics had total assets of $424.1M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Sarepta Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for SRPT stock stand at $87.41M.

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover

Quarterly Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, BioCryst Pharma balance sheet, Blueprint Medicines balance sheet, Gilead Sciences balance sheet, Halozyme Therapeutics balance sheet